» Articles » PMID: 20066508

Hepatitis C Virus Evasion of Adaptive Immune Responses: a Model for Viral Persistence

Overview
Journal Immunol Res
Date 2010 Jan 13
PMID 20066508
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis C virus (HCV) infects over 170 million people worldwide and is a leading cause of cirrhosis and hepatocellular carcinoma. Approximately 20% [corrected] of those acutely infected clear the infection, whereas the remaining 80% [corrected] progress to chronic infection. Hepatitis C thus provides a model in which successful and unsuccessful responses can be compared to better understand the human response to viral infection. Our laboratory studies the strategies by which HCV evades the adaptive immune response. This review describes the impact of viral mutation on T cell recognition, the role of cell surface inhibitory receptors in recognition of HCV, and the development of antibodies that neutralize HCV infection. Understanding what constitutes an effective immune response in the control of HCV may enable the development of prophylactic and therapeutic vaccines for HCV and other chronic viral infections.

Citing Articles

Contemporary Insights into Hepatitis C Virus: A Comprehensive Review.

Sallam M, Khalil R Microorganisms. 2024; 12(6).

PMID: 38930417 PMC: 11205832. DOI: 10.3390/microorganisms12061035.


Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors.

Yibirin M, Mustafayev K, Hosry J, Pundhir P, Klingen J, Yepez Guevara E Am J Gastroenterol. 2023; 118(9):1609-1617.

PMID: 37307533 PMC: 11809494. DOI: 10.14309/ajg.0000000000002361.


CD8 T-Cell Exhaustion Phenotype in Chronic Hepatitis C Virus Infection Is Associated With Epitope Sequence Variation.

Osuch S, Laskus T, Perlejewski K, Berak H, Bukowska-Osko I, Pollak A Front Immunol. 2022; 13:832206.

PMID: 35386708 PMC: 8977521. DOI: 10.3389/fimmu.2022.832206.


Sero-reactivity to three distinct regions within the hepatitis C virus alternative reading frame protein (ARFP/core+1) in patients with chronic HCV genotype-3 infection.

Elsheikh M, McClure C, Tarr A, Irving W J Gen Virol. 2022; 103(3).

PMID: 35230930 PMC: 9176264. DOI: 10.1099/jgv.0.001727.


A short hepatitis C virus NS5A peptide expression by AAV vector modulates human T cell activation and reduces vector immunogenicity.

Colon-Moran W, Baer A, Lamture G, Stapleton J, Fischer J, Bhattarai N Gene Ther. 2021; 29(10-11):616-623.

PMID: 34759330 PMC: 9091046. DOI: 10.1038/s41434-021-00302-5.


References
1.
Draenert R, Le Gall S, Pfafferott K, Leslie A, Chetty P, Brander C . Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J Exp Med. 2004; 199(7):905-15. PMC: 2211885. DOI: 10.1084/jem.20031982. View

2.
Kato N, Ootsuyama Y, Tanaka T, Nakagawa M, Nakazawa T, Muraiso K . Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res. 1992; 22(2):107-23. DOI: 10.1016/0168-1702(92)90038-b. View

3.
Chisari F, Ferrari C . Hepatitis B virus immunopathogenesis. Annu Rev Immunol. 1995; 13:29-60. DOI: 10.1146/annurev.iy.13.040195.000333. View

4.
Wolfl M, Rutebemberwa A, Mosbruger T, Mao Q, Li H, Netski D . Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire. J Immunol. 2008; 181(9):6435-46. PMC: 2742502. DOI: 10.4049/jimmunol.181.9.6435. View

5.
Cox A, Mosbruger T, Lauer G, Pardoll D, Thomas D, Ray S . Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology. 2005; 42(1):104-12. PMC: 2759395. DOI: 10.1002/hep.20749. View